Our previous research indicated that reduced FKBP5 levels in endometrial adenocarcinoma tissues promote cancer cell proliferation by increasing p-AKT levels while simultaneously decreasing the sensitivity of these cancer cells to progesterone therapy. Here, AKT1 is linked to cancer.